108 related articles for article (PubMed ID: 28463790)
1. Dexmedetomidine inhibits activation of the MAPK pathway and protects PC12 and NG108-15 cells from lidocaine-induced cytotoxicity at its maximum safe dose.
Wang Q; Tan Y; Zhang N; Xu Y; Wei W; She Y; Bi X; Zhao B; Ruan X
Biomed Pharmacother; 2017 Jul; 91():162-166. PubMed ID: 28463790
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine protects PC12 cells from lidocaine-induced cytotoxicity via downregulation of Stathmin 1.
Tan Y; Bi X; Wang Q; Li Y; Zhang N; Lao J; Liu X
Drug Des Devel Ther; 2019; 13():2067-2079. PubMed ID: 31308624
[No Abstract] [Full Text] [Related]
3. Dexmedetomidine protects against lidocaine-induced neurotoxicity through SIRT1 downregulation-mediated activation of FOXO3a.
Zheng LN; Guo FQ; Li ZS; Wang Z; Ma JH; Wang T; Wei JF; Zhang WW
Hum Exp Toxicol; 2020 Sep; 39(9):1213-1223. PubMed ID: 32228195
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine Protects PC12 Cells from Lidocaine-Induced Cytotoxicity Through Downregulation of COL3A1 Mediated by miR-let-7b.
Wang Q; She Y; Bi X; Zhao B; Ruan X; Tan Y
DNA Cell Biol; 2017 Jul; 36(7):518-528. PubMed ID: 28436683
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine Protects Against Chemical Hypoxia-Induced Neurotoxicity in Differentiated PC12 Cells Via Inhibition of NADPH Oxidase 2-Mediated Oxidative Stress.
Chen XH; Chen DT; Huang XM; Chen YH; Pan JH; Zheng XC; Zeng WA
Neurotox Res; 2019 Jan; 35(1):139-149. PubMed ID: 30112693
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of dexmedetomidine on neuronal hypoxic injury through inhibition of miR-134.
Li YJ; Zhang DZ; Xi Y; Wu CA
Hum Exp Toxicol; 2021 Dec; 40(12):2145-2155. PubMed ID: 34121490
[TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine Reduces the Lidocaine-Induced Neurotoxicity by Inhibiting Inflammasome Activation and Reducing Pyroptosis in Rats.
Ding XD; Cao YY; Li L; Zhao GY
Biol Pharm Bull; 2021; 44(7):902-909. PubMed ID: 34193687
[TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine Attenuates Glutamate-Induced Cytotoxicity by Inhibiting the Mitochondrial-Mediated Apoptotic Pathway.
Zhang W; Yu J; Guo M; Ren B; Tian Y; Hu Q; Xie Q; Xu C; Feng Z
Med Sci Monit; 2020 May; 26():e922139. PubMed ID: 32419697
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine Alleviates Lipopolysaccharide-Induced Hippocampal Neuronal Apoptosis via Inhibiting the p38 MAPK/c-Myc/CLIC4 Signaling Pathway in Rats.
Chen Y; Li L; Zhang J; Cui H; Wang J; Wang C; Shi M; Fan H
Mol Neurobiol; 2021 Nov; 58(11):5533-5547. PubMed ID: 34363182
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine attenuates acute lung injury induced by lipopolysaccharide in mouse through inhibition of MAPK pathway.
Xu Y; Zhang R; Li C; Yin X; Lv C; Wang Y; Zhao W; Zhang X
Fundam Clin Pharmacol; 2015 Oct; 29(5):462-71. PubMed ID: 26211495
[TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine exerts neuroprotective effects during high glucose-induced neural injury by inhibiting miR-125b.
Hou X; Xu F; Zhang C; Shuai J; Huang Z; Liang Y; Xu X
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32538430
[TBL] [Abstract][Full Text] [Related]
12. Both PI3K/Akt and ERK1/2 pathways participate in the protection by dexmedetomidine against transient focal cerebral ischemia/reperfusion injury in rats.
Zhu YM; Wang CC; Chen L; Qian LB; Ma LL; Yu J; Zhu MH; Wen CY; Yu LN; Yan M
Brain Res; 2013 Feb; 1494():1-8. PubMed ID: 23219579
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of miRNA-151-3p enhanced the neuroprotective effect of dexmedetomidine against β-amyloid by targeting DAPK-1 and TP53.
Guo Y; Wu Y; Li N; Wang Z
Exp Mol Pathol; 2021 Feb; 118():104587. PubMed ID: 33275947
[TBL] [Abstract][Full Text] [Related]
14. Protective role of Bcl-2 on beta-amyloid-induced cell death of differentiated PC12 cells: reduction of NF-kappaB and p38 MAP kinase activation.
Song YS; Park HJ; Kim SY; Lee SH; Yoo HS; Lee HS; Lee MK; Oh KW; Kang SK; Lee SE; Hong JT
Neurosci Res; 2004 May; 49(1):69-80. PubMed ID: 15099705
[TBL] [Abstract][Full Text] [Related]
15. Both JNK and P38 MAPK pathways participate in the protection by dexmedetomidine against isoflurane-induced neuroapoptosis in the hippocampus of neonatal rats.
Liao Z; Cao D; Han X; Liu C; Peng J; Zuo Z; Wang F; Li Y
Brain Res Bull; 2014 Aug; 107():69-78. PubMed ID: 25026397
[TBL] [Abstract][Full Text] [Related]
16. [Protective effect of dexmedetomidine against glutamate-induced cytotoxicity in PC12 cells and its mechanism].
Zhang WD; Zhang H; Wang H; Zhang N; DU CY; Yu J; Feng ZG
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Feb; 37(2):150-156. PubMed ID: 28219856
[TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine (12.5 μg/mL) improves tissue distribution, anesthetic action, and hemodynamic effects of lidocaine after palatal infiltration in rats.
Akimoto T; Hashimoto S; Sunada K
Odontology; 2016 Sep; 104(3):390-6. PubMed ID: 26695161
[TBL] [Abstract][Full Text] [Related]
18. Neurotoxicity of sub-anesthetic doses of sevoflurane and dexmedetomidine co-administration in neonatal rats.
Perez-Zoghbi JF; Zhu W; Neudecker V; Grafe MR; Brambrink AM
Neurotoxicology; 2020 Jul; 79():75-83. PubMed ID: 32387222
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine dose-dependently enhances local anesthetic action of lidocaine.
Ouchi K; Koga Y; Nakao S; Sugiyama K
J Oral Maxillofac Surg; 2014 Mar; 72(3):474-80. PubMed ID: 24268964
[TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine Protects Neural Stem Cells from Ketamine-Induced Injury.
Lu P; Lei S; Li W; Lu Y; Zheng J; Wang N; Xia Y; Lu H; Chen X; Liu Y; Zhang PB
Cell Physiol Biochem; 2018; 47(4):1377-1388. PubMed ID: 29929189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
